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Ion-exchange high-performance liquid chromatography was employed as a screening method 
for abnormal hemoglobins in the newborn period. Samples of cord blood collected in EDTA 
tubes were used for this analysis. Hemolysates were injected onto 4.1 X loo-mm Synchropak 
ion-exchange columns using an automatic injector. Hemoglobin separation was carried out 
by means of a sodium acetate gradient. A total of 415 samples was analyzed. Hemoglobins 
A, F, and Bart’s, as well as C or S when present, were separately eluted and quantitated using 
a 35min gradient program. Four individuals with sickle cell disease, 26 with S or C trait, one 
with SC disease, and two others with alpha-chain variants were diagnosed with this method. 
The proportion of Bart’s hemoglobin was greater than 1% in 33 individuals. The elution pattern 
was highly reproducible. The potential for complete automation and the ease with which 
quality control can be assured make this technique well suited for the detection of abnormal 
hemoglobins in the newborn period. 
Neonatal screening for abnormal hemo- 
globins provides a practical approach for the 
detection of sickling syndromes and other 
hemoglobin disorders such as a-thalassemia. 
Most screening programs utilize various 
electrophoretic techniques for the detection 
of abnormal hemoglobins ( l-4). Electropho- 
resis on cellulose acetate at pH 8.6 identifies 
increased amounts of Bart’s hemoglobin 
(Hb)* associated with alpha thalassemia ( 1). 
However, hemoglobins F, A, and S are not 
always well resolved from each other. Elec- 
trophoresis on citrate agar at pH 6.2 pro- 
vides better separation of Hb F from Hb S; 
however, Bart’s Hb is not easily detectable. 
Some screening programs utilize both of 
these techniques because of the limitations 
* This paper was presented at the International Sym- 
posium on HPLC of Proteins and Peptides, November 
16-17, 1981, Washington, D. C. 
’ Supported in part by NIH Grant HL25541. 
2 Abbreviations used: Hb, hemoglobin; HPLC, high- 
performance liquid chromatography. 
of each when used separately (4). Micro- 
column chromatography (5) has also been 
used for newborn screening. Another re- 
cently described technique is thin-layer iso- 
electric focusing (6). Neither microcolumn 
chromatography nor isoelectric focusing has 
been useful for the quantitation of Bart’s Hb 
(7). Recently ion-exchange high-perfor- 
mance liquid chromatography (HPLC) has 
been utilized for the separation of hemoglo- 
bin types (8). We have therefore investigated 
the use of HPLC in cord blood screening for 
hemoglobin disorders. 
MATERIALS AND METHODS 
Blood samples. Cord blood samples from 
black newborns were collected into EDTA- 
containing tubes. Red cells were isolated by 
centrifugation, washed three times with 
physiological saline, and hemolyzed with 
equal volumes of distilled water and toluene. 
The toluene fraction containing cellular de- 
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FIG. I. HPLC separation of hemoglobins in hemoiysates from three newborns: (a) normal, (b) HbC 
trait, and (c) with increased levals of Bart’s Hb, using a 35min gradient-program. Column: Synchropak 
AX 300, 4.1 X 100 mm. Sample volume: 20 ~1. Gradient parameters: flow rate 1.5 ml/min. Mobile 
phase at time 0: 100% buffer A (0.02 M Tris, 100 mg/titer KCN, pH 8.6) and 100% buffer B at 35 min 
(0.02 M Tris, 0.2 M Na acetate, pH 7.0). R~ujlihrat~on was accomplished by pumping buffer A for IO 
min. Notice the increased anlounts of Hb F 11 due to aging of the hemolysate. All three samples were 
separated on the same column. 
bris was removed following centrifugation. 
An aiiquot of the hemolysate was immedi- 
ately utilized for cellulose acetate electro- 
pboresis (9) and the remainder was kept fro- 
zen at -4’C for subsequent HPLC analysis, 
In some cases blood was also collected from 
other relatives for family studies. Some in- 
fants were restudied at 2 to 7 months of age 
to evaluate changes in the hemogtobin HPLC 
pattern. 
HPLC c~ru~u~~gr~~~~. The HPLC sys- 
tem used consisted of a Varian Model 5020 
gradient liquid chromatograph (Varian In- 
struments, Palo Alto, Calif.). The hemofy- 
sate was injected onto the column either 
manually or automatically using an auto- 
matic injector (Varian Instruments). Syn- 
chropak AX300 (10) ion-exchange columns 
measuring 4.1 X 100 mm were used (Syn- 
chrom, Linden, Ind.). The support consisted 
of a IO-pm macroporous spherical silica with 
a bonded poiymeric layer of amine. Initially, 
columns packed by the manufacturer were 
utilized. Subsequently, however, because of 
variability in retention times from batch to 
batch of ion exchanger, ail columns were 
prepared in the laboratory from the same 
batch of ion exchanger (11). Elution was 
accomplished using a linear gradient of buff- 
ers A and 3. Buffer A consisted of 0.02 M 
Tris, 100 mgfliter KCN; pH 8.6. Buffer 3 
consisted of 0.02 M Tris, 0.2 M Na acetate, 
pH 7.0. The pH of all buffers was adjusted 
with acetic acid. Buffer A was used for equil- 
ibration. Initially, several programs with dif- 
ferent flow rates and gradient slopes were 
utilized. Subsequently, however, a 35-min 
program consisting of 100% buffer A (0% 
buffer B) at time 0 and 100% buffer I3 at 35 
min with a flow rate of 1.5 ml/min was uti- 
lized. Operating column pressure was 500 
psi. Column reequilibration was accom- 
plished by pumping bufFer A for 10 min at 
a flow rate of 1.5 mlfmin. Separation was 
carried out at room temperature. Absor- 
bance was monitored at 415 nm with a vari- 
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FIG. 2. Chromatographic separation of hemoglobins in hemolysates from (a) a newborn with sickle 
cell disease and (b) a newborn with Hb G Philadelphia. Conditions are the same as in Fig. 1, except 
a longer 60-min program was used with 100% buffer A at time 0 and 50% buffer B at 60 min with a 
Row rate of 1.0 ml/min. Notice the small amount of Hb F II in (a). 
able wavelength detector. The proportion of 
the separated hemoglobin peaks was com- 
puted using a Beckman Model 126 data sys- 
tem (Beckman, Palo Alto, Calif.). Stored 
hemolysates were diluted fivefold with buffer 
A, followed by centrifugation at 10,OOOg for 
10 min prior to chromatography. Ten to 
twenty microliters of the final hemolysate 
preparation were injected onto the column. 
RESULTS 
Elution Pattern 
The order in which various hemoglobins 
were eluted was similar to that observed with 
conventional anion-exchange chromatogra- 
phy (Figs. l-3). By means of a 35min pro- 
gram with a flow rate of 1.5 ml/min, four 
major peaks were identified in hemolysates 
from normal newborns. Hb A was eluted 
separately, followed by the major Hb F peak, 
a Hb FI shoulder, and a Hb FII peak. The 
proportion of the Hb FII fraction was vari- 
able and gradually increased with the aging 
of the hemolysates. Freshly prepared sam- 
ples contained approximately 3-5s of Hb 
FII, while hemolysates that had been stored 
in the refrigerator for 3 to 6 months con- 
tained up to 35% of Hb FII. Freezing of the 
hemolysate reduced the effect of aging on 
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FIG. 3. Chromatographic separation of hemoglobins 
from a newborn with elevated levels of Bart’s Hb. Con- 
ditions are the same as in Fig. 2, except a different 
column was used. A small shoulder is noted following 
the major Bart’s Hb peak. 
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Hb FII but did not eliminate it completely. 
Dialysis in the presence of 0.5% 2-mercap 
t~thanol for 2 to 6 h was asociated with a 
reduction in the proportion of Hb FII. Stor- 
age had little effect on the proportion of Hb 
FI, which amounted to 8-10% of the total 
hemoglobin (Fig. 1). To determine the iden- 
tity of Hb FI, hemoglobins in newborn hem- 
olysates were first separated on Bio-Rex col- 
umns ( 12). Each of the hemoglobin fractions 
collected was subsequently analyzed by ion- 
exchange HPLC. Only the acetylated Hb F 
fraction collected off the Bio-Rex column 
had an identical elution time as Hb FL 
Abnormal samples encountered among 
4 I 5 newborns studied included 4 FS, 1 FSC, 
22 FAS, and 4 FAC patterns. Two unrelated 
infants had an alpha-chain variant identified 
as Hb G Philadelphia by peptide analysis. 
Hemoglobins A, S, and C when present were 
eluted separately (Figs. 1 and 2). The pro- 
portion of Hb S in samples showing a FAS 
pattern was quite variable. As little as 2% 
Hb S was present in some hemolysates. Pat- 
terns corresponding to newborns with sickle 
cell anemia did not include any peaks be- 
tween S and F when fresh hemolysates were 
used. However, after storage in the refrig- 
erator for 2 to 4 weeks a small peak amount- 
ing to 2-4% of the total hemoglobin was 
noted in the Hb A position. The appearance 
of this peak was associated with a corre- 
sponding decrease in the size of the Hb S 
peak. 
Hemolysates that showed a striking in- 
crease in Bart’s Hb by cellulose acetate elec- 
trophoresis (6-8% of the total hemolysate) 
were utilized to determine the elution time 
of Bart’s Hb by HPLC. Newborns from 
whom these hemolysates were obtained had 
abnormal red blood cell indices indicative of 
thalassemia. The HPLC pattern for the 
hemolysates contained a late-eluting peak 
not present in patterns obtained from normal 
newborns (Figs. l-3). The size of the late- 
eluting peak corresponded well to the amount 
of Bart’s Hb on cellulose acetate electro- 
phoresis. The major peak corresponding to 
Bart’s Hb was followed by a small shoulder 
when relatively flat gradients were utilized 
(Fig. 3). The shoulder was less noticeable 
using the shorter 35min gradient program 
(Fig. 1). Of all the newborn hemolysates 
studied, 33 contained a Bart’s Hb peak that 
represented 1% or more of the total hemo- 
globin. 
Reproducibiliry 
The elution time for different hemoglobin 
types was remarkably constant from run to 
run using the same column and gradient 
program and did not differ by more than 0.2 
min from the expected value. However, the 
elution time was quite variable from column 
to column, For example, in the case of the 
35-min program, there was as much as a 5- 
min difference in elution time for a hemo- 
globin type between columns. The difference 
was related to the packing material because 
much less variability was encountered when 
columns prepared from the same batch of 
ion exchanger were utilized. 
Hb G Philadelphia in hemolysates from 
two newborns and their relatives consistently 
eluted in the same position, which was 2 min 
later than Hb S with the 35-min gradient 
program. This observation, coupled with the 
presence of two major peaks in the Hb F 
region, clearly indicated the presence of an 
alpha-chain variant (Fig. 2b). The repro- 
ducibility of the technique extends to the 
quantitation of the different hemoglobin 
types in hemolysates. The proportion of var- 
ious hemoglobins did not differ by more than 
1% in 10 consecutive runs of a hemolysate 
that gave a FAS pattern. The reproducibility 
is best illustrated in the case of one of the 
two newborns with Hb G Philadelphia who 
was studied at birth and later at 4 and 7 
months of age. Both parents of this infant 
were also studied (Table 1). The presence 
of equal amounts of normal and variant Hbs 
A and F, coupled with increased amounts 
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TABLE 1 
QUANT~TATIONOFHEMOGLOBINTYPESINHEMOLYSATESFROMAFAMILY 












- - 5.8 7.2 38.2 46.3 2.5 44.0 
1.0 1.1 40.4 43.1 5.8 8.6 - 47.2 
1.0 1.4 43.6 46.2 3.8 4.0 - 48.4 
0.8 1.6 34.5 60.3 2.8 - 35.5 
- 2.1 - 95.0 2.9 - - 
of Bart’s Hb at birth was strongly suggestive 
of a homozygous state for a deletion of one 
of the two active alpha genes in the infant 
(cw6-/a-genotype). The smaller proportion of 
HB G Philadelphia in the father was sug- 
gestive of a deletion of one of the four alpha 
genes (cuG-farce-genotype). It was therefore 
concluded that the infant’s mother had an 
alpha gene deletion to account for the pres- 
ence of only two active alpha genes in the 
infant. These conclusions, based on the 
HPLC quantitation of the normal and vari- 
ant hemoglobins, were confirmed by restric- 
tion endonuclease mapping of the alpha glo- 
bin genes (13). 
The proportion of Bart’s Hb in hemoly- 
sates containing increased amounts of this 
hemoglobin did not appreciably decrease 
even after several months of storage of the 
hemolysates, if they were kept frozen at 
-4°C. However, quantitation of small 
amounts of Bart’s Hb (less than 1%) was not 
reproducible in multiple runs. 
It is noteworthy that in the two cases of 
Hb G Philadelphia, the presence of an alpha- 
chain variant was missed by electrophoresis 
because there was no splitting of the Hb F 
band and the only abnormal Hb band noted 
was in the Hb S position. In addition, a 
Hb A band in four individuals who had a 
FAS pattern by HPLC was not obvious by 
electrophoresis because of poor resolution 
from Hb F. 
DISCUSSION 
Screening for abnormal hemoglobins in 
the newborn period differs from screening 
in other age groups because of the presence 
of large amounts of Hb F and the need to 
detect and quantitate Bart’s Hb, which is 
only transiently increased at birth in alpha 
thalassemia. In contrast, quantitation of the 
small amounts of Hb A2, which is increased 
in beta-thalassemia, is an important part of 
screening in the older group but not in the 
newborn period. Hb A2 is an early eluting 
peak, whereas Bart’s Hb is the last peak to 
come off the column. Consequently, HPLC 
analysis of hemoglobins in the newborn pe- 
riod requires the use of gradient programs 
different from those used for the older age 
group. Adequate resolution was achieved 
using a higher ionic strength for bufFer B 
and a higher f?ow rate than have been used 
before ( 14,15 ). 
Several factors have an important effect 
on the separation of hemoglobins by ion-ex- 
change HPLC. These have been discussed 
in detail elsewhere (14). In particular, the 
use of columns prepared from different 
batches of ion exchanger requires slight 
modifications in the gradient program to en- 
sure optimal resolution. Obviously, it is nec- 
essary to use hemoglobin standards with ev- 
ery new column to establish the elution time 
of different hemoglobin types. 
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The results described above indicate that 
hemoglobin analysis by ion-exchange HPLC 
combines the advantages of several other 
techniques. This includes excellent separa- 
tion of hemoglobins A, S, and F. Further- 
more, the elution time for Hb S was different 
from that of Hb G Philadelphia. Also, in a 
previous study, Hb D Punjab differed in its 
elution time from Hb S. 
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